Executive Summary
Across 18 NASDAQ-100 related SEC filings from April 1, 2026, dominant themes include transformative M&A activity (CWBC merger, KDP JDE Peet's acquisition, LUNR $800M Lanteris buy, CYH $459M asset sale) signaling consolidation in banking, beverages, space, and healthcare, with combined entities boasting $5B+ assets or $16B+ revenues. Period-over-period trends show revenue growth in land development (MLP +68% YoY to $19.5M, leasing +1000% YoY to $5.8M) and financing inflows (FF +100% YoY cash to $161.4M), but persistent operating losses (FF $331M FY2025, MLP net loss +43% to $10.6M) and pro forma declines (CYH revenues - $327M). Positive catalysts include Nasdaq compliance regains (Immunic), product validations (AITX), and equity turnarounds (FF stockholders' equity +$7.7M from negative), while neutral proxy filings (UCBI, Intellicheck) and institutional ownership (WMG 13G 5.1%) indicate routine governance. Portfolio-level patterns reveal mixed sentiment (7 positive/mixed growth, 9 neutral), with capital raises via stock sales (Cottonwood $3.6M) and debt optimization supporting turnarounds amid Nasdaq bid price pressures (FF notice). Market implications favor M&A beneficiaries for near-term synergies but flag liquidity risks in loss-making firms.
Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from March 25, 2026.
Investment Signals(12)
- CWBC(BULLISH)▲
Merger with UBFO completed April 1, 2026, creating $5B asset bank with all-stock deal at $185.5M valuation (0.4520 shares/share), positive sentiment, systems conversion summer 2026
- KDP(BULLISH)▲
Acquired 96.22% JDE Peet's (EUR 9.9B 2025 sales), plans split into Beverage Co. and Global Coffee Co. by YE 2026, forming $16B+ revenue powerhouse
- Immunic↓(BULLISH)▲
Regained Nasdaq compliance (bid >$1 for 20 days Feb 27-Mar 26, 2026), Phase 3 IMU-838 top-line data E2026
- Cottonwood Communities↓(BULLISH)▲
Raised $2.4M from 239k Series A Preferred + $1.3M from 130k Series 2025 Preferred in March 2026, ongoing $150M placements to accredited investors
- FF(BULLISH)▲
Stockholders' equity turned positive $7.7M (from negative), $161.4M financing inflow +100% YoY, EAI Robotics 22 units shipped Q1 2026 exceeding targets with positive margins
- MLP(BULLISH)▲
Land Development Sales rev +68% YoY to $19.5M, Leasing rev +1000% YoY to $5.8M, op income swing to +$1.8M profit, Adjusted EBITDA +146% to $1.8M
- CYH(BULLISH)▲
Sold Crestwood Medical assets for $459M cash April 1, 2026, $185M pre-tax gain ($138M after-tax), pro forma cash +$450M improving stockholders' deficit
- AITX(BULLISH)▲
RAD system retained by new property owner post-sale, validating autonomous security performance
- LUNR(BULLISH)▲
$800M Lanteris acquisition closed Jan 13, 2026 ($450M cash + $350M stock), audited financials provided showing integration progress
- BKNG(BULLISH)▲
Appointed Kurt Sievers (ex-NXP CEO) to board April 1, 2026, adding tech/M&A expertise amid Lynn Radakovich retirement June 2026
- MLP(BULLISH)▲
FY2025 op loss narrowed 38% to $4.5M, G&A + share comp -15% to $9.1M despite pension hit
- FF(BULLISH)▲
SEC investigation closed March 2026 no action, first FX Super One vehicle roll-off Dec 2025
Risk Flags(8)
- FF/Compliance[HIGH RISK]▼
Nasdaq deficiency notice March 20, 2026 for bid <$1, 180 days to comply post-Q4 FY2025 results
- MLP/Net Loss[HIGH RISK]▼
FY2025 net loss widened 43% to $10.6M from $7.4M due to $6.6M pension termination (mostly non-cash), cash convertible -44% to $5.3M
- CYH/Pro Forma[HIGH RISK]▼
Post-sale pro forma net loss to stockholders +$101M to $610M for YE2025, op revenues -$327M despite $450M cash boost
- FF/Operations[HIGH RISK]▼
FY2025 op loss $331M ($185M ex-impairments), flat revenue YoY, op cash outflow $107.5M
- Scinai/Losses↓[HIGH RISK]▼
History of operating losses, no profitability, risks from CDMO partner dependencies and regulatory anti-kickback laws delaying pipeline
- MLP/Liquidity[MEDIUM RISK]▼
Line of credit +$1M to $4M YE2025, cash/investments -44% to $5.3M, unidentified segment rev -41% YoY to $0.8M with wider loss
- FF/Equity Volatility[MEDIUM RISK]▼
Equity positive $7.7M after ~$100M debt optimization but from deep negative base amid ongoing Nasdaq issues
- CYH/Operations[MEDIUM RISK]▼
Sold assets do not qualify as discontinued, pro forma expenses reduced but net loss deteriorated
Opportunities(8)
- CWBC/Merger Synergies(OPPORTUNITY)◆
$5B asset combined entity across 31 Central CA communities, 14-member board, leadership stability with new Vice Chairman, summer 2026 systems conversion for efficiency gains
- KDP/Global Coffee Spin(OPPORTUNITY)◆
JDE Peet's integration + split by YE2026 creates focused entities (Beverage $16B rev + Coffee EUR9.9B), Rafael Oliveira as CEO, post-acceptance delisting April 30
- Immunic/Clinical Catalyst↓(OPPORTUNITY)◆
Phase 3 vidofludimus calcium top-line E2026 for MS, pipeline IMU-856/IMU-381, fresh Nasdaq compliance
- FF/EAI Robotics(OPPORTUNITY)◆
Q1 2026 exceeded targets (22 units shipped, +gross margins), FX Super One production started, post-debt optimization equity positive
- Cottonwood/Funding Momentum↓(OPPORTUNITY)◆
$3.6M March 2026 raises via preferred stock (Reg D 506(b)), $150M max offerings for growth capital
- CYH/Balance Sheet(OPPORTUNITY)◆
$459M cash from sale +$450M pro forma, $138M after-tax gain reduces deficit, potential debt paydown/de-risking
- MLP/Leasing Growth(OPPORTUNITY)◆
15 new leases 2025 drove +33% leasing rev to $12.8M, land holdings 22k acres Maui, agave venture deferred costs $1.7M
- LUNR/Space Expansion(OPPORTUNITY)◆
$800M Lanteris acquisition financials audited, pro forma YE2025 data supports scaled operations
Sector Themes(5)
- M&A Consolidation Wave◆
4/18 filings (CWBC $185.5M merger, KDP JDE EUR9.9B, LUNR $800M, CYH $459M sale) show banking/beverage/space/healthcare deals at 0.452-1.0x implied multiples, implying synergies and scale in fragmented sectors [IMPLICATION: Buy post-deal dips for integration alpha]
- Mixed Revenue vs Loss Trends◆
Revenue growth in 3/18 (MLP +68% land/+1000% leasing, FF cash +100% YoY, Cottonwood $3.6M raises) but losses widened avg +40% (MLP +43%, CYH pro forma +20%, FF $331M op loss), highlighting growth-at-cost dynamics [IMPLICATION: Favor margin improvers over topline-only]
- Nasdaq Compliance Pressures◆
2/18 (FF deficiency notice March 20, Immunic regained), bid price issues common in speculative tech/space/biotech [IMPLICATION: Monitor 180-day windows for reverse splits/delisting risks]
- Capital Raises via Equity◆
Preferred stock sales (Cottonwood $3.6M March), debt tender (MU multiple notes), asset monetization (CYH +$450M cash) vs traditional buybacks/dividends absent [IMPLICATION: Dilution risk but liquidity bolsters turnarounds]
- Governance/Proxy Surge◆
5/18 neutral proxies (UCBI x2, Intellicheck, abrdn, BKNG board) with May/June 2026 meetings, institutional 13G (WMG 5.1%) signal routine but watch say-on-pay [IMPLICATION: Low volatility, potential activist entry]
Watch List(8)
- CWBC/Systems Conversion👁
Monitor summer 2026 integration post-UBFO merger for cost savings/deposit growth [Summer 2026]
- KDP/Split Timeline👁
Track operational readiness and delisting April 30, 2026 for Global Coffee Co. spin YE2026 [YE2026]
- FF/Nasdaq Compliance👁
180-day window from March 20, 2026 notice for $1 bid price, EAI/FX production updates [By Sep 2026]
Top-line vidofludimus calcium results end 2026, post-compliance momentum [E2026]
- MLP/Cash Burn👁
Liquidity at $5.3M YE2025, agave venture $1.7M deferred, new leases impact [Ongoing 2026]
- CYH/Pro Forma Impacts👁
Post-$459M sale adjustments, Q1 2026 earnings for gain realization/debt moves [Q1 Earnings TBD]
- abrdn Fund/Reorg Vote👁
Adjourned meeting April 15, 2026 for MFS merger quorum [April 15, 2026]
- UCBI/Annual Meeting👁
Virtual May 13, 2026 vote on directors/comp/auditors, proxy solicitation ongoing [May 13, 2026]
Filing Analyses(18)
01-04-2026
Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 1, 2026, under Item 8.01 announcing the issuance of a press release titled 'AITX's RAD Retained Through Property Sale as New Owner Validates Autonomous Security Performance.' The press release, attached as Exhibit 99.1, highlights the retention of AITX's RAD system by a property's new owner post-sale, validating its autonomous security capabilities. No financial metrics or period comparisons were disclosed.
- ·Filing is furnished under Item 8.01 and not deemed 'filed' for liability purposes.
- ·Registrant details: Nevada incorporation, CIK 0001498148, EIN 27-2343603, principal office at 10800 Galaxie Avenue, Ferndale, Michigan 48220.
01-04-2026
Faraday Future reported Q4 and FY 2025 results with stockholders’ equity turning positive at $7.7 million after ~$100 million debt optimization and financing cash inflow of $161.4 million, up 100% YoY from $80.7 million. EAI Robotics exceeded first-month targets with 22 units shipped and positive product gross margins in Q1 2026, while achieving the first FX Super One pre-production vehicle roll-off. However, revenue was flat YoY, operating loss reached $331 million for FY 2025 ($185 million excluding one-time impairments), and operating cash outflow was $107.5 million.
- ·SEC investigation concluded in March 2026 with no enforcement action.
- ·Nasdaq deficiency notice received March 20, 2026, for minimum bid price below $1.00; 180 days to comply.
- ·First FX Super One pre-production vehicle rolled off December 21, 2025, at Hanford, CA AI-Factory.
- ·EAI Robotics targeting >1,000 cumulative shipments by end December 2026.
- ·Headquarters relocated to Silicon Beach, El Segundo, CA in March 2026.
- ·Initiated action on potential illegal short selling and market manipulation in March 2026.
01-04-2026
For the year ended December 31, 2025, Maui Land & Pineapple Co Inc (MLP) showed strong growth in Land Development and Sales revenues (+68% YoY to $19.5M) and Leasing revenues (over 1,000% YoY to $5.8M), while Resort Amenities revenues increased 23% YoY to $12.8M but operating income declined 6% YoY. However, an unidentified segment saw revenues drop 41% YoY to $0.8M with wider operating loss, and overall net loss expanded to $10.6M from $7.4M primarily due to $6.9M in pension expenses, with basic/diluted loss per share at $(0.54) vs $(0.38). Total land holdings remained at 22,286 acres across West and Upcountry Maui.
- ·West Maui land breakdown: 19 acres commercial/industrial, 866 acres residential/resort/mixed-use, 8,871 acres agricultural, 11,045 acres conservation/watershed.
- ·Land Development and Sales operating loss improved to $(4.5M) from $(7.4M) YoY.
- ·Leasing operating income swung to $1.8M profit from $(0.6M) loss YoY.
- ·Company reviews long-lived assets for impairment based on cash flow estimates and classifies assets as held for sale under specific criteria including management commitment and active marketing.
01-04-2026
Maui Land & Pineapple Company reported FY2025 operating revenues up 68% YoY to $19.5 million, driven by leasing revenues increasing 33% to $12.8 million and land development and sales net operating income surging 416% to $5.8 million. Adjusted EBITDA improved 146% to $1.8 million, operating loss narrowed 38% to $4.5 million, and combined G&A and share-based compensation expenses decreased 15% to $9.1 million. However, net loss widened 43% to $10.6 million due to $6.6 million pension plan termination expense (mostly non-cash), and cash and investments convertible to cash fell to $5.3 million from $9.5 million.
- ·Executed 15 new leases in 2025 to aid leasing revenue growth.
- ·Line of credit balance: $4.0 million as of Dec 31, 2025 (up from $3.0 million current in 2024).
- ·Deferred development costs for agave venture: $1.7 million as of Dec 31, 2025.
01-04-2026
Keurig Dr Pepper Inc. (KDP) has acquired 96.22% of the shares of JDE Peet’s N.V., combining it with KDP’s Keurig coffee business to form a global coffee powerhouse as part of its strategic transformation. KDP plans to separate into two independent U.S.-listed companies—Beverage Co. and Global Coffee Co.—targeting operational readiness by year-end 2026, with Rafael Oliveira appointed as CEO of the future Global Coffee Co. KDP has annual revenue of more than $16 billion and 30,000 employees, while JDE Peet’s generated EUR 9.9 billion in 2025 sales with more than 21,000 employees.
- ·Post-Closing Acceptance Period for JDE Peet’s shares: March 30, 2026, to April 13, 2026
- ·Last day of trading JDE Peet’s shares on Euronext Amsterdam: April 29, 2026
- ·Delisting of JDE Peet’s shares from Euronext Amsterdam: April 30, 2026
- ·Offer Memorandum dated January 15, 2026
01-04-2026
Immunic, Inc. received notification from Nasdaq on March 27, 2026, confirming it has regained compliance with Listing Rule 5550(a)(2) Minimum Bid Price Requirement after maintaining a $1.00 per share closing bid price for 20 consecutive business days from February 27 to March 26, 2026, closing the matter. The company issued a press release on April 1, 2026, announcing this development. No negative performance metrics reported; the company highlighted its ongoing Phase 3 trials for vidofludimus calcium (IMU-838) with top-line data expected by end of 2026.
- ·Immunic's lead program vidofludimus calcium (IMU-838) in Phase 3 for relapsing multiple sclerosis.
- ·Pipeline includes earlier-stage programs IMU-856 and IMU-381 for neurodegenerative, chronic inflammatory, and autoimmune diseases.
- ·Annual Report on Form 10-K for fiscal year ended December 31, 2025, filed February 26, 2026.
01-04-2026
Scinai Immunotherapeutics Ltd. reports a history of operating losses and lack of current profitability, despite generating revenues from its CDMO activities, with risks of continued losses due to market demand dependencies and partner performance issues. The company highlights competitive strengths in its dual business model combining R&D drug development with CDMO operations, which provides financial flexibility, generates external revenues, and supports internal programs to reduce cash burn. However, regulatory risks including state anti-kickback laws and partner failures could delay pipeline commercialization and impact revenues.
01-04-2026
Cottonwood Communities, Inc. reported sales of 239,119 shares of Series A Convertible Preferred Stock for $2,369,181 in gross proceeds during March 11-31, 2026, with $124,160 in commissions and $68,522 in placement fees paid. Additionally, the company sold 130,077 shares of Series 2025 Preferred Stock for $1,277,000 in gross proceeds over March 16-31, 2026, incurring $55,620 in commissions and $37,872 in placement fees. These sales are part of ongoing private placements with maximum offerings of $150,000,000 each.
- ·Offerings exempt under Rule 506(b) of Regulation D, sold solely to accredited investors without general solicitation.
- ·Series A Convertible launched September 19, 2023; Series 2025 launched December 9, 2024; both at $10.00 per share.
01-04-2026
Intuitive Machines, Inc. (LUNR) filed an 8-K/A amendment to provide audited historical consolidated financial statements of Lanteris Space Holdings LLC for the years ended December 31, 2025 and 2024 (Exhibit 99.1), and unaudited pro forma condensed combined financial information as of and for the year ended December 31, 2025 (Exhibit 99.2), following the consummation of its $800 million acquisition of Lanteris on January 13, 2026. The acquisition consideration consisted of $450 million in cash and $350 million in Class A Common Stock, pursuant to a purchase agreement dated November 3, 2025. No other changes were made to the original 8-K filed January 13, 2026.
- ·Acquisition first announced on November 4, 2025
- ·Membership Interest Purchase Agreement dated November 3, 2025
- ·Historical audited financials cover years ended December 31, 2025 and 2024
- ·Pro forma financials as of and for year ended December 31, 2025
- ·Consent of KPMG LLP filed as Exhibit 23.1
01-04-2026
Booking Holdings Inc. (BKNG) appointed Kurt Sievers, retired CEO of NXP Semiconductors, to its Board of Directors effective April 1, 2026, bringing experience in technology, mobility, and global markets from roles including leading NXP's acquisition of Marvell’s Wi-Fi Connectivity Business Unit and the 2015 merger with Freescale Semiconductor. Concurrently, Director Lynn Radakovich announced her retirement from the Board effective at the company's Annual Meeting in June 2026 after a decade of service providing leadership in global business, technology, sales, and marketing.
- ·Kurt Sievers served as President and CEO of NXP Semiconductors from 2020 until retirement in 2025; previously President from 2018 and joined Executive Management Team in 2009.
- ·Kurt Sievers currently serves on boards of Capgemini SE (Strategy & CSR and Compensation Committees) and supervisory board of Daimler Truck Holding AG.
- ·Filing date: April 01, 2026; Items 5.02, 7.01, 9.01.
01-04-2026
abrdn National Municipal Income Fund (NYSE: VFL) adjourned its Special Shareholder Meeting on April 1, 2026, to April 15, 2026, at 11:00 am Eastern Time, to solicit additional proxies and achieve quorum. The meeting concerns approval of an Agreement and Plan of Reorganization with MFS Municipal Income Trust (NYSE: MFM), which the Board of Trustees unanimously recommends. Aberdeen Investments, the manager, had approximately $525 billion in assets under management as of December 31, 2025.
- ·Proxy materials available on www.sec.gov and via mail.
- ·Contact: Aberdeen Investments U.S. Closed-End Funds Investor Relations at 1-800-522-5465 or investor.relations@aberdeenplc.com
01-04-2026
Intellicheck, Inc. (Nasdaq: IDN) filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders on May 7, 2026, held virtually via webcast, to elect six directors for one-year terms, ratify Forvis Mazars, LLP as independent auditors for fiscal 2026, approve executive compensation on an advisory basis, and vote on the frequency of future say-on-pay votes. The record date is March 23, 2026, with 20,239,060 shares of common stock outstanding, each entitled to one vote. No financial performance metrics or period-over-period changes are detailed in the filing.
- ·Quorum requires a majority of the combined voting power of Common Stock as of March 23, 2026.
- ·Directors elected by plurality vote; auditor ratification, say-on-pay, and frequency vote each require majority of votes cast.
- ·Proxy materials available at https://intellicheck.com/investors.
01-04-2026
Community Health Systems, Inc. completed the sale of substantially all assets and certain liabilities of Crestwood Medical Center and associated outpatient centers in Huntsville, Alabama, to The Health Care Authority of the City of Huntsville d/b/a Huntsville Hospital Health System on April 1, 2026, for $459 million in cash (subject to post-closing adjustments). The transaction resulted in an estimated pre-tax gain of $185 million ($138 million after tax), boosting pro forma cash by $450 million and improving stockholders' deficit. However, pro forma net operating revenues declined by $327 million, and net loss attributable to stockholders increased to $610 million from $509 million for the year ended December 31, 2025.
- ·Agreement entered into on January 20, 2026.
- ·Facility operations do not qualify as discontinued operations under ASC 205.
- ·Pro forma adjustments eliminate $327M revenues, $123M salaries/benefits, $63M supplies, $88M other operating expenses, $11M lease cost, $13M depreciation/amortization, and reflect $185M gain/(loss) on sale.
01-04-2026
Micron Technology, Inc. issued a press release on March 31, 2026, announcing the pricing of its cash tender offers for any and all outstanding senior notes, including 5.300% due 2031, 5.650% due 2032, 5.875% due 2033 (2033A and 2033B Notes), 5.800% due 2035 (2035A Notes), and 6.050% due 2035 (2023B Notes), which were commenced on March 25, 2026. On April 1, 2026, the Company announced the expiration of these tender offers via another press release. No specific tender amounts, acceptance levels, or pricing details were disclosed in the filing.
- ·Tender offers commenced on March 25, 2026.
- ·Press releases attached as Exhibit 99.1 (March 31, 2026) and Exhibit 99.2 (April 1, 2026).
01-04-2026
United Community Banks, Inc. (UCBI) has issued Definitive Additional Proxy Materials (DEFA14A) for its 2026 Annual Shareholder Meeting scheduled virtually on May 13, 2026, at 3:00 PM ET. Shareholders are voting on the election of 12 director nominees, advisory approval of Named Executive Officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2026. Proxy materials are available online at www.ProxyVote.com or can be requested in paper/email form by April 29, 2026.
- ·Voting deadline: May 12, 2026, 11:59 PM ET (May 10, 2026, 11:59 PM ET for shares in a Plan)
- ·Virtual meeting URL: www.virtualshareholdermeeting.com/UCBI2026
- ·Company address: 200 East Camperdown Way, Greenville, South Carolina 29601
- ·Material request methods: www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com (include control number)
01-04-2026
United Community Banks, Inc. (UCBI) has issued its 2026 Proxy Statement for the virtual Annual Meeting of Shareholders on May 13, 2026 at 3:00 p.m. ET, seeking shareholder approval for electing 12 director nominees, an advisory vote to approve Named Executive Officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2026. The Board recommends voting FOR all three proposals. Shareholders of record as of March 16, 2026 are eligible to vote.
- ·Record date for voting eligibility: March 16, 2026.
- ·Voting methods: Internet (www.proxyvote.com), phone (1-800-690-6903), mail, or during virtual meeting at www.virtualshareholdermeeting.com/UCBI2026.
- ·Fiscal year references: 2025 (ended December 31, 2025), 2026 (ending December 31, 2026).
- ·12 director nominees, with 11 independent and H. Lynn Harton as non-independent CEO.
- ·No family relationships among directors, executive officers, or nominees.
01-04-2026
Darlington Partners Capital Management, LP, Darlington Partners GP, LLC, Darlington Partners, L.P., Scott W. Clark, and Ramsey B. Jishi filed Schedule 13G on April 1, 2026, disclosing beneficial ownership of 7,551,884 shares of Warner Music Group Corp.'s Class A Common Stock as of March 25, 2026, equating to 5.1% of the 146,965,855 shares outstanding per the company's Form 10-Q filed February 4, 2026, for the quarter ended December 31, 2025. The filers report the shares are held by investment adviser clients, including Darlington Partners, L.P., with no single client other than Darlington exceeding 5%. They file jointly but disclaim group membership or beneficial ownership beyond pecuniary interest, certifying passive investment not intended to influence control.
- ·Shares outstanding figure from Form 10-Q for quarter ended December 31, 2025.
- ·Filers certify holdings acquired and held in ordinary course of business, not for purpose of changing or influencing control.
Get daily alerts with 12 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 18 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)